Skip to main
ATOS
ATOS logo

Atossa Genetics (ATOS)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Atossa Genetics (ATOS) Stock

About Atossa Genetics (ATOS)

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.
Market cap$103.75M
Today's volume874.26K
Revenue (TTM)
Avg. daily volume691.24K
EBITDA (TTM)-$28.04M
Open$0.83
Price / earnings ratio-3.87x
Today's range$0.79 - $0.83
Debt / equity
52 week range$0.55 - $1.66
5 year debt / equity
Beta (LTM)1.38x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio12.67x
Ex-dividend date
Next earningsAug 11, 2025
Dividend payable date

Atossa Genetics Stock Rating

What analysts recommend for ATOS stock, on a scale from 1(buy) to 5(sell).
Strong Buy
Strong Buy 83%
Buy 17%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jun 19, 2025, the market cap for ATOS stock is $103.75M

The current P/E ratio for ATOS stock is -3.87

The 52-week high for ATOS stock is $1.66. The current ATOS stock price $undefined is 100.00% below its 52-week high

The 52-week low for ATOS stock is $0.55. The current ATOS stock price $undefined has increased 100.00% from its 52-week low

No, the ATOS stock does not pay dividends to its shareholders

The target price for ATOS stock is $6.92 based on the average of what a group of analyst think ATOS stock could be worth at a future date. This is not a prediction by Public.com

How to buy ATOS stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ATOS stock

    Navigate to the Explore page. Then, type ATOS into the search bar. When you see ATOS stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ATOS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Atossa Genetics Stock Earnings

The value each ATOS share was expected to gain vs. the value that each ATOS share actually gained.

Atossa Genetics (ATOS) reported Q1 2025 earnings per share (EPS) of -$0.05, meeting estimates of -$0.05 by 0.00%. In the same quarter last year, Atossa Genetics's earnings per share (EPS) was -$0.05. Atossa Genetics is expected to release next earnings on 08/11/2025, with an earnings per share (EPS) estimate of -$0.06.

Buy Atossa Genetics (ATOS) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.